How do I communicate where I’m at in the clinical translation continuum?

A presentation by Mary Sunderland, PhD (Foundation Fighting Blindness) and Dawn Richards, PhD (Clinical Trials Ontario) at the Bench to Bedside for Biotherapeutics (B3) Workshop held in Toronto on October 5, 2017.

A candid discussion with Dawn Richards from Clinical Trials Ontario talking about the importance of how communicating with patients and key stakeholder along the clinical pipeline in invaluable for clinical adaption. Speaking as both a patient advocate and through her role with CTO, Dawn Richards has a unique and important perspective for researchers.

This video is presented by the Clinical Translation Education Group:  BioCanRx, CCRM, CellCAN, Foundation Fighting Blindness, Ontario Institute for Cancer Research, Ontario Institute for Regenerative Medicine and Stem Cell Network.

All other pages contact

For more information, please contact us.
Font Resize
Enable Contrast